Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-19T11:46:53.048Z Has data issue: false hasContentIssue false

5 - Neuroprotection in cerebral ischemia

from PART I - INTRODUCTION AND GENERAL PRINCIPLES

Published online by Cambridge University Press:  05 August 2016

Jin-Moo Lee
Affiliation:
Washington University School of Medicine
Dennis W. Choi
Affiliation:
Department of Neurosciences Merck Research Laboratories
Arthur K. Asbury
Affiliation:
University of Pennsylvania School of Medicine
Guy M. McKhann
Affiliation:
The Johns Hopkins University School of Medicine
W. Ian McDonald
Affiliation:
University College London
Peter J. Goadsby
Affiliation:
University College London
Justin C. McArthur
Affiliation:
The Johns Hopkins University School of Medicine
Get access

Summary

Ischemic stroke is a consequence of transient or permanent reduction of blood flow to a focal region of the brain, usually caused by the occlusion of an artery by an embolus or thrombus. Cerebral ischemia may also occur globally in the setting of cardiac arrest and resuscitation. While historically brain damage has been considered to be an inexorable consequence of focal or global ischemic insults, in recent years a growing understanding of the underlying mechanisms responsible for brain cell death has led to the identification of new therapeutic approaches. Two main approaches have emerged. The first aims to restore lost blood flow by dissolving the thrombus responsible for cerebral artery obstruction (in ischemic stroke). Thrombolysis has become an established treatment for ischemic stroke after the efficacy of intravenous tissue plasminogen activator (tPA) was demonstrated in a landmark study (The NINDS rt-PA Stroke Study Group, 1995). Promising results have also been reported for the thrombolytic agent pro-urokinase, delivered by intra-arterial catheter directly to the site of intravascular thrombus (Furlan et al., 1999). The second approach, neuroprotection, aims to reduce the intrinsic vulnerability of brain tissue to ischemia; it will be the topic of this chapter.

Mechanisms of ischemic neuronal death

The brain is more vulnerable to ischemia than many other tissues, so it seems plausible that the cellular mechanisms of this heightened vulnerability could be delineated and blocked. Over the last 15 years evidence has accumulated indicating that normal brain signaling and immune defense mechanisms may become harmful after ischemic insults (Rothman & Olney, 1986; Choi, 1988; del Zoppo et al., 2000). In particular, substantial evidence now implicates excitotoxicity, programmed cell death, and inflammation in the pathogenesis of ischemic neuronal death.

Excitotoxicity

The excitatory transmitter glutamate normally mediates most fast synaptic transmission throughout the CNS, but it also has a surprising ability to trigger central neuronal death upon prolonged exposure, a phenomenon called ‘excitotoxicity’ by Olney (1969). Excitotoxicity now appears to be involved in the pathogenesis of several CNS diseases including ischemic brain injury (Rothman & Olney, 1986; Choi, 1988). Under ischemic conditions, neurons deprived of oxygen and glucose r apidly lose ATP and become depolarized, leading to abnormally high levels of glutamate release (initially mediated by vesicular release from nerve terminals, and later by reverse transport from astrocytes).

Type
Chapter
Information
Diseases of the Nervous System
Clinical Neuroscience and Therapeutic Principles
, pp. 62 - 78
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×